Journal of Cancer Research and Therapeutics

REVIEW ARTICLE
Year
: 2012  |  Volume : 8  |  Issue : 3  |  Page : 343--347

Personalized medicine of esophageal cancer


Lei Wang1, Hui-Yi Yang2, Yong-Qing Zheng2 
1 Department of Cardiothoracic Surgery, Hebei Medical University Fourth Hospital, ShiJiaZhuang, Hebei, China
2 SurExam Bio Tech Co. Ltd., Guangzhou Technology Innovation Base, Science City, Guangzhou, China

Correspondence Address:
Yong-Qing Zheng
SurExam Bio Tech Co. Ltd., Guangzhou Technology Innovation Base, Science City, Guangzhou
China

The fatality rate of esophageal carcinomas is high in developing countries, making effective treatment desirable. Traditional treatment has now entered into the platform, and treatments based on the detection of biomarkers increasingly become a trend. This review presents several biomarkers of esophageal cancer, including chemotherapy-related biomarkers and targeted drug-related biomarkers, and the correlation of these biomarkers with drug response.


How to cite this article:
Wang L, Yang HY, Zheng YQ. Personalized medicine of esophageal cancer.J Can Res Ther 2012;8:343-347


How to cite this URL:
Wang L, Yang HY, Zheng YQ. Personalized medicine of esophageal cancer. J Can Res Ther [serial online] 2012 [cited 2020 Sep 27 ];8:343-347
Available from: http://www.cancerjournal.net/article.asp?issn=0973-1482;year=2012;volume=8;issue=3;spage=343;epage=347;aulast=Wang;type=0